Drug Type Biological products |
Synonyms SYNCON CSPG4 |
Action modulators |
Mechanism Chondroitin sulfate proteoglycans modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | United States | - | |
Melanoma | Preclinical | United States | - |